Cargando…
Molecular-Targeted Therapies for Hematologic Malignancies
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254001/ https://www.ncbi.nlm.nih.gov/pubmed/22242021 http://dx.doi.org/10.1155/2012/606423 |
_version_ | 1782220790826008576 |
---|---|
author | Bunting, Kevin D. Qu, Cheng-Kui Tomasson, Michael H. |
author_facet | Bunting, Kevin D. Qu, Cheng-Kui Tomasson, Michael H. |
author_sort | Bunting, Kevin D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3254001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-32540012012-01-12 Molecular-Targeted Therapies for Hematologic Malignancies Bunting, Kevin D. Qu, Cheng-Kui Tomasson, Michael H. Adv Hematol Editorial Hindawi Publishing Corporation 2012 2011-12-28 /pmc/articles/PMC3254001/ /pubmed/22242021 http://dx.doi.org/10.1155/2012/606423 Text en Copyright © 2012 Kevin D. Bunting et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Bunting, Kevin D. Qu, Cheng-Kui Tomasson, Michael H. Molecular-Targeted Therapies for Hematologic Malignancies |
title | Molecular-Targeted Therapies for Hematologic Malignancies |
title_full | Molecular-Targeted Therapies for Hematologic Malignancies |
title_fullStr | Molecular-Targeted Therapies for Hematologic Malignancies |
title_full_unstemmed | Molecular-Targeted Therapies for Hematologic Malignancies |
title_short | Molecular-Targeted Therapies for Hematologic Malignancies |
title_sort | molecular-targeted therapies for hematologic malignancies |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254001/ https://www.ncbi.nlm.nih.gov/pubmed/22242021 http://dx.doi.org/10.1155/2012/606423 |
work_keys_str_mv | AT buntingkevind moleculartargetedtherapiesforhematologicmalignancies AT quchengkui moleculartargetedtherapiesforhematologicmalignancies AT tomassonmichaelh moleculartargetedtherapiesforhematologicmalignancies |